期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
TDP-43 regulates cancer-associated microRNAs 被引量:4
1
作者 xiaowei Chen Zhen Fan +9 位作者 Warren McGee Mengmeng Chen Ruirui Kong Pushuai Wen tengfei xiao xiaomin Chen Jianghong Liu Li Zhu Runsheng Chen Jane Y. Wu 《Protein & Cell》 SCIE CAS CSCD 2018年第10期848-866,共19页
regulation of miRNA genes contributes to pathogenesis of a wide range of human diseases, including cancer. The TAR DNA binding protein 43 (TDP- 43), a RNAJDNA binding protein associated with neu- rodegeneration, is ... regulation of miRNA genes contributes to pathogenesis of a wide range of human diseases, including cancer. The TAR DNA binding protein 43 (TDP- 43), a RNAJDNA binding protein associated with neu- rodegeneration, is involved in miRNA biogenesis. Here, we systematically examined miRNAs regulated by TDP- 43 using RNA-Seq coupled with an siRNA-mediated knockdown approach. TDP-43 knockdown affected the expression of a number of miRNAs. In addition, TDP-43 down-regulation led to alterations in the patterns of dif- ferent isoforms of miRNAs (isomiRs) and miRNA arm selection, suggesting a previously unknown role of TDP- 43 in miRNA processing. A number of TDP-43 associ- ated miRNAs, and their candidate target genes, are associated with human cancers. Our data reveal highly complex roles of TDP-43 in regulating different miRNAs and their target genes. Our results suggest that TDP-43 may promote migration of lung cancer cells by regulat- ing miR-423-3p. In contrast, TDP-43 increases miR-500a- 3p expression and binds to the mature miR-500a-3p sequence. Reduced expression of miR-500a-3p is associated with poor survival of lung cancer patients,suggesting that TDP-43 may have a suppressive role in cancer by regulating miR-500a-3p. Cancer-associated genes LIF and PAPPA are possible targets of miR-500a- 3p. Our work suggests that TDP-43-regulated miRNAs may play multifaceted roles in the pathogenesis of cancer. 展开更多
关键词 TDP-43 MIRNA CANCER MIGRATION PROGNOSIS
原文传递
CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant Melanoma
2
作者 Ziyi Li Binbin Wang +14 位作者 Shengqing Gu Peng Jiang Avinash Sahu Chen-Hao Chen Tong Han Sailing Shi xiaoqing Wang Nicole Traugh Hailing Liu Yin Liu Qiu Wu Myles Brown tengfei xiao Genevieve M.Boland X.Shirley Liu 《Genomics, Proteomics & Bioinformatics》 SCIE CAS CSCD 2020年第1期26-40,共15页
BRAF is a serine/threonine kinase that harbors activating mutations in^7%of human malignancies and^60%of melanomas.Despite initial clinical responses to BRAF inhibitors,patients frequently develop drug resistance.To i... BRAF is a serine/threonine kinase that harbors activating mutations in^7%of human malignancies and^60%of melanomas.Despite initial clinical responses to BRAF inhibitors,patients frequently develop drug resistance.To identify candidate therapeutic targets for BRAF inhibitor resistant melanoma,we conduct CRISPR screens in melanoma cells harboring an activating BRAF mutation that had also acquired resistance to BRAF inhibitors.To investigate the mechanisms and pathways enabling resistance to BRAF inhibitors in melanomas,we integrate expression,ATAC-seq,and CRISPR screen data.We identify the JUN family transcription factors and the ETS family transcription factor ETV5 as key regulators of CDK6,which together enable resistance to BRAF inhibitors in melanoma cells.Our findings reveal genes contributing to resistance to a selective BRAF inhibitor PLX4720,providing new insights into gene regulation in BRAF inhibitor resistant melanoma cells. 展开更多
关键词 Drug resistance CRISPR screen MELANOMA BRAF inhibitor Gene regulation
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部